My hunch is that the share price will get to at least $2.50 upon announcement of NDA filing with the FDA. That equates to a MC of approx $385 million. Between now and then we may hear of more KOLs being onboarded as prescribers and prescriptions issued to keep up with strong demand as part of the growth plan under the SAS in AU. There is then potential news of exploring further indication that could be treated. Of course, nothing is guaranteed so these are just my musings.
My hunch is that the share price will get to at least $2.50 upon...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $31.34M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.5¢ | $86.44K | 308.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 77717 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 50000 | 2 |
View Market Depth
| Last trade - 15.59pm 19/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |